Skip to content

Drug interactions

Glipizide-metformin + Tranylcypromine

Severity: Moderate

Glipizide-metformin and Tranylcypromine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

MAO inhibitors can intensify the glucose-lowering effect of antidiabetic drugs and lead to hypoglycemia. This is particularly relevant for the sulfonylurea component.

What this interaction means in plain words

Glipizide-metformin and Tranylcypromine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Glipizide-metformin belongs to Endocrine; Tranylcypromine belongs to Central Nervous System.

Evidence level: Low

Why it happens

The mechanism is not well established; MAO inhibition may enhance insulin secretion or sensitivity.

What to do

Monitor blood glucose closely when tranylcypromine is started, changed or stopped. Reduce the glipizide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glipizide-metformin and Tranylcypromine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glipizide-metformin with Tranylcypromine?

MediHelp rates the interaction as moderate. Glipizide-metformin and Tranylcypromine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. MAO inhibitors can intensify the glucose-lowering effect of antidiabetic drugs and lead to hypoglycemia. This is particularly relevant for the sulfonylurea component.

How serious is the interaction between Glipizide-metformin and Tranylcypromine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely when tranylcypromine is started, changed or stopped. Reduce the glipizide dose if hypoglycemia occurs.

What other medicines interact with Glipizide-metformin?

MediHelp also lists interactions of Glipizide-metformin with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Glipizide-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in